Journal of Histochemistry and Cytochemistry, Vol. 49, 1261-1268, October 2001, Copyright © 2001, The Histochemical Society, Inc.


ARTICLE

A Comparative Quantitative Analysis of Laminin-5 in the Basement Membrane of Normal, Hyperplastic, and Malignant Oral Mucosa by Confocal Immunofluorescence Imaging

K. Michael Haasa,b, Alexander Berndta, Klaus J. Stillera, Peter Hyckelb, and Hartwig Kosmehla
a Institute of Pathology, Friedrich Schiller University, Jena, Germany
b Clinic of Maxillofacial Surgery, Friedrich Schiller University, Jena, Germany

Correspondence to: Hartwig Kosmehl, Institute of Pathology, Friedrich Schiller University, D-07740 Jena, Germany. E-mail: kosmehl@bach.med.uni-jena.de


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Laminin-5 (Ln-5) is a heterotrimeric basement membrane (BM) molecule ({alpha}3ß3{gamma}2). It is a principal protein constituent of the anchoring filaments, which connect the BM with the hemidesmosomes of the basal keratinocytes and possess a crucial function in keratinocyte adhesion. Confocal immunofluorescence imaging is introduced for a quantitative evaluation of the Ln-5 content in the BM of oral squamous epithelium. The BM of normal oral mucosa was used as a reference (100%) for comparative analysis and showed a nearly uniform Ln-5 immunofluorescence intensity (99–100%). In all hyperplastic lesions of oral mucosa, the Ln-5 immunofluorescence intensity was increased (107–141%). The increased Ln-5 content in the BM of hyperplastic lesions suggests an increased keratinocyte–BM adhesion, possibly resulting in a higher stability of the oral mucosa. In contrast, in the oral squamous cell carcinoma (OSCC) invasive front, the remaining BM segments were characterized by a decrease in Ln-5 immunofluorescence intensity (35–74%). A stronger decrease of Ln-5-linked kerationocyte-BM adhesion correlates with a higher tumor grade. Because in central areas of carcinoma BM segments with a normal Ln-5 content could be demonstrated, the fundamental Ln-5 diminution in BM segments of the invasive front should be considered as an invasion-associated phenomenon.

(J Histochem Cytochem 49:1261–1268, 2001)

Key Words: laminin-5, invasion, squamous cell carcinoma, confocal laser scanning microscopy


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

A VARIETY of morphological changes of the basement membrane (BM) are known to occur in degenerative, inflammatory, or neoplastic diseases. The BM modifications are ultrastructurally classified by a thinning or attenuation of the membrane with or without breaks in its continuity, a thickening of the membrane, reduplications, or deposits within the membrane (for review see Damjanov 1990 ; Ghadially 1997 ). In addition to these various structural irregularities, modifications of the BM can be associated with qualitative changes in the protein content. Different cell or tissue types can be discriminated by means of their laminin isoforms (Kosmehl et al. 1996 ; Strassburger et al. 1998 ). Moreover, the grade of maturation can be determined by the deposition of distinct laminin chains in the BM (Miner and Sanes 1994 ; Kosmehl et al. 1999 ).

In contrast to the well-documented structural irregularities and the qualitative differences in the protein content of the BM, only little is known concerning quantitative variations of the BM protein content. Owing to the signal amplification of enzyme-based immunohistochemical techniques and the projection of all immunohistochemical signals of a BM protein yielded from a usual 4-µm-thick immunohistochemical slide in one level, only few variations of the signal intensity occur and a nearly uniform BM staining is seen independent of possible quantitative variations of the protein within the BM. In consequence, for carcinomas a "black-and-white picture" of the BM is accepted in general, because segments with immunohistochemically normal BM exist adjacent to segments with a complete loss of BM proteins (breaks).

Confocal laser scanning microscopy (CLSM) allows the excitation of a fluorochrome and the collection of the emitted light in a defined narrow level within the slide. Quantitative evaluation of the emitted light yields information about the number of primary antibody-binding proteins in the defined level of the BM.

Among the BM constituents, special attention has been devoted to laminin-5 (Ln-5; {alpha}3ß3{gamma}2), a member of the growing laminin molecule family. Ln-5 has been identified in the BM of squamous epithelium, where it is localized in the anchoring filaments. These filaments connect the hemidesmosomes of the cell with the basal lamina (Rousselle et al. 1991 ). Mutations in the genes of Ln-5 cause a loss of the basal keratinocyte–BM adhesion, resulting in epidermolysis junctionalis bullosa Herlitz (Matsui et al. 1998 ).

Whereas the structural irregularities of the BM and qualitative variations of the BM proteins are well documented in association with several disease processes, only little is known about quantitative variations. Therefore, we have introduced a procedure for quantitative confocal immunofluorescence imaging of BM proteins.

Because Ln-5 plays a crucial role in the epithelial cell–BM adhesion and may be modified in reactive or tumor lesions, we have analyzed the keratinocyte–BM adhesion via a comparison of the Ln-5 content in the BM of normal, hyperplastic, and carcinomatous oral mucosa.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Tissue Material
The study included five samples of normal buccal and gingival mucosa, six cases of hyperplasia of oral mucosa, and 18 cases of oral squamous cell carcinoma (OSCC). Samples of 4 mm2, including the epithelial–stromal interface or the deep invasive margins of OSCC, were shock-frozen in isopropanol, cooled by liquid nitrogen, and stored at -75C. The diagnosis and tumor grade were confirmed in the cryostat sections and in the corresponding paraffin-embedded tissue according to the revised WHO classification and Bryne's malignancy grading (Bryne et al. 1992 ; Pindborg et al. 1997 ).

Immunofluorescence Labeling
Four-µm-thick cryostat sections of the respective frozen tissue samples were fixed in ice-cooled acetone for 15 min and subsequently subjected to immunofluorescence labeling. The immunofluorescence labeling for collagen Type IV (CIV22, 1:50; Odermatt et al. 1984 ) was used to indentify the BM region in serial sections. The laminin chain immunolabelings (Ln-{alpha}3 chain: BM165, 1:5000; Rousselle et al. 1991 ; Ln-ß3 chain: 6F12, 1:50; Marinkovich et al. 1992 ; Ln-{gamma}2 chain: GB3, 1:10; Hsi and Yeh 1986 ; Ln-{gamma}2 chain: D4B5; Mizushima et al. 1998 ) were interpreted behind the background of the collagen Type IV-based BM identification. The Ln-{gamma}2 chain occurs exclusively in Ln-5. In contrast to the clone D4B5, which recognizes only the Ln-{gamma}2 chain alone or in combination with the Ln-ß3 chain and/or Ln-{alpha}3 chain, the monclonal antibody GB3 recognizes the Ln-{gamma}2 chain only in the heterotrimeric molecule. Therefore, GB3 was used for quantitative analysis of the assembled Ln-5 molecule (Matsui et al. 1995 ).

The primary antibodies were diluted in a background-reducing medium (Dako; Glostrup, Denmark). The incubation with the primary antibody was carried out overnight at 4C. After being washed with a Tris buffer, the sections were incubated with secondary goat anti-mouse FITC-conjugated antibodies (Dianova; Hamburg, Germany) diluted 1:50 in a RPMI cell culture medium (BioWhittaker Europa; Verviers, Belgium) for 45 min at room temperature (RT). After rinsing, the slides were mounted with Vectashield (Vector Laboratories; Burlingame, CA) to prevent bleaching (Florijn et al. 1995 ). As a negative control, the primary antibody was replaced by a non-immune serum.

Laser Scanning Microscopy
The fluorescence labeling was analyzed by CLSM (LSM 510, ApoChromat x40; Zeiss, Jena, Germany) immediately after the fluorescence labeling procedure. The 488-nm line of the argon laser (LASOS; Jena, Germany) was used to excite the FITC. For the quantitative Ln-5 evaluation, the laser was set to 25% power output and 2% excitation. With these settings no bleaching was observed during the measurement period. The FITC-mediated emission was detected using the LSM-510 configuration "FITC narrow band" (HST 488, filter BP 505-550; Zeiss). The pinhole was set to 90 µm (1 airy unit) and the amplification gain was set to 1. To provide an optimal dynamic range for the measurement, the amplification offset and the detector gain were adjusted for each slide. The nonspecific fluorescence of the background, calculated from areas without Ln-5 deposits, was determined as the threshold value.

To evaluate the Ln-5 content within the areas of BM breaks in the OSCC, the CLSM was set at maximal sensitivity.

Measurement Procedure
For the quantitative analysis, two tissue sections were mounted on one slide: a sample of normal oral mucosa as a reference and a sample of non-normal mucosa, by which the immunofluorescence intensity should signal a variation of Ln-5, on the other. To identify the histopathology before scanning, both sample and reference were visually evaluated using differential interference contrast (DIC).

Using constant settings, five representative high-power Fields (HPFs) of the non-normal sample and five HPFs of the reference mucosa were scanned with 512 x 512 pixels. The images were recorded with 8 bits per pixel, resulting in 255 intensity levels. Using the "area" function of the LSM-510 software, the intensity of Ln-5 immunofluorescence above the threshold was measured (mean intensity per pixel). Areas with artifacts or necrosis were excluded. A periodic (non-continuous) LSM analysis of the same slides or switching the laser illumination off and on was avoided to prevent variations in the laser intensity.

For a comparative evaluation, the immunofluorescence intensity of the sample was given as a percent of the immunofluorescence intensity yielded from the reference (normal oral mucosa) mounted on the same slide.

Statistical Analysis
The significance of the deviations of the mean fluorescence intensity as measured from normal, hyperplastic, and carcinomatous mucosa as well as within G1, G2, and G3 oral carcinomas was performed using the Exact Mann–Whitney test (SPSS, Version 10; SPSS, Chicago, IL).


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Ln-5 in Normal Mucosa, Hyperplastic Mucosa, and OSCC Using Conventional Immunofluorescence Microscopy
With monoclonal antibodies to the {alpha}3-, ß3-, and {gamma}2-chains of Ln-5 in normal adult squamous epithelium, a narrow and sharply contoured immunolabeling was demonstrated in agreement with collagen Type IV immunolabeling at the epithelial–stromal interface (BM region) (Fig 1A). In hyperplastic lesions of oral mucosa, the Ln-5 immunostaining was retained in the BM region. Compared to the Ln-5 immunostaining of the normal oral epithelium, the BM showed irregularities that included thickening and a blurred outline. No BM breaks were observed (Fig 1B). Only a few small Ln-5 spots were seen beneath the BM within the stromal compartment. In the OSCC, fundamental irregularities of Ln-5 immunolabeling occurred. Three distinct patterns could be distinguished: a cytoplasmic Ln-5 immunolabeling within the invading carcinoma cell complexes; many defects in Ln-5 immunolabeling of the BM; and spots of Ln-5 within the stromal compartment adjacent to invading OSCC cell complexes. In contrast to the Ln-{gamma}2-chain antibody D4B5 and the Ln-ß3-chain antibody, the Ln-{gamma}2 antibody GB3 revealed, if at all, only sparse and weak immunolabeling outside the collagen Type IV-marked BM region. The Ln-{alpha}3-chain was also detected in pre-existing vessels (Fig 1C–1F).



View larger version (97K):
[in this window]
[in a new window]
 
Figure 1. Demonstration of Ln-5 in normal, hyperplastic, and carcinomatous oral mucosa by CLSM. In normal oral mucosa a uniform Ln-5 immunofluorescence labeling of the BM is demonstrated (A). Compared to normal oral mucosa, in hyperplasia the Ln-5 immunofluorescence is increased and the BM shows a thickening (B, antibody GB3 to the {gamma}2 chain of Ln-5). Deep invasive edges of an G2 OSCC (C; HE). In serial sections, different antibodies to Ln-5 chains were applied. The {gamma}2-chain antibody GB3 shows a low immunofluorescence intensity in the retained BM segments in the invasive front (lower part), whereas in more central areas (upper part) strong immunofluorescence is detected (D). In contrast to the antibody GB3, the {gamma}2-chain antibody D4B5 shows a strong cytoplasmic labeling covering the BM (E). The {alpha}3-chain antibody BM165 additionally detects {alpha}3 signals outside the epithelial BM, e.g., in blood vessels (F). Bars = 50 µm.

Ln-5 Content in the BM of Normal Oral Mucosa
Under the following conditions [all compared tissue samples on the same slide, a standardized immunolabeling procedure (monoclonal antibody GB3), laser and filter settings kept constant, and a continuous (unbroken) laser scanning in the microscopic evaluation] the immunofluorescent analysis of the Ln-5 content in the BM of normal oral mucosa showed only minimal variations (Fig 2A and Fig 2B). The analysis showed a nearly uniform Ln-5 immunofluorescence intensity (99–100%; Table 1) in the BM of the normal oral mucosa, indicating a uniform Ln-5 content and distribution independent of the localization. The mounting of two different tissue samples on one slide enables the comparative and reproducible analysis of the Ln-5 immunofluorescence intensities.



View larger version (84K):
[in this window]
[in a new window]
 
Figure 2. Demonstration of the Ln-5-{gamma}2-chain immunofluorescence intensity in the BM of normal oral epithelium (A,B) and in OSCC invasive front (C,D) using confocal laser scanning microscopy. (A) The Ln-5-{gamma}2-chain immunofluorescence intensity in the BM of normal oral epithelium for comparison. (C) The gradient of Ln-5-{gamma}2-chain immunofluorescence intensity is demonstrated, with the lowest level of immunofluorescence intensity in the retained BM segments of the invasive front (lower part). ca, carcinoma cell complexes; pet, pre-existing tissue. Differential interference contrast. (B,D) The different levels of Ln-5 immunofluorescence intensity are demonstrated by different colors. In central areas of OSCC the immunofluorescence intensity is only minimally reduced and BM segments with a normal Ln-5 immunofluorescence occur (red color, arrows). Antibody GB3. Bars = 50 µm.


 
View this table:
[in this window]
[in a new window]
 
Table 1. Clinicopathological data and immunofluorescence intensity values

Ln-5 Content in BM of Hyperplastic Lesions of Oral Mucosa
An increase of Ln-5 immunofluorescence in the BM of all hyperplastic lesions of oral mucosa (monoclonal antibody GB3) could be detected (Table 1; Fig 3). Compared to normal oral mucosa, the fluorescence intensity was raised to minimal 107% and maximal 141% and proved to be significant (p=0.01).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Variation of the Ln-5 immunofluorescence intensity in the BM of normal and hyperplastic oral epithelium as well as in the OSCC invasive front in relation to malignancy grade (Bryne et al. 1992 ).

Ln-5 Content in BM of OSCC
The detection of the extent of BM breaks is dependent on the intensity of the laser light illumination used. Despite the use of high-powered laser illumination, a complete focal loss of Ln-5 (all antibodies against Ln-5 chains) or collagen Type IV immunofluorescence from the BM was demonstrated.

There was an Ln-5 immunofluorescence gradient within the tumor, visible with all antibodies applied to chains of Ln-5. The Ln-5 content of the remaining/newly forming BM of the invasive front was lower than in the more central areas of the carcinoma. The center of the OSCC contained BM segments with Ln-5 immunofluorescence intensities comparable to those of normal oral mucosa. Moreover, the number and extent of the BM breaks were lower here than in the invasive front (Fig 2B and Fig 2C).

In all the carcinoma samples, the Ln-5 content of the retained BM in the invasive front was statistically significantly reduced (p<0.001) compared to the normal oral mucosa (35–74%). With a higher OSCC malignancy grade, a diminution of the Ln-5 content occurred within the retained/reestablished BMs of the invasive front (Table 1; Fig 3). This difference was particularly pronounced if the malignancy grading of OSCC invasive front according to Bryne and co-workers (1992) is applied (G1–G2 p=0.04; G2–G3 p= 0.035; G1-G2/3 p<0.001; Table 1).


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Pyke and co-workers (1994) described an increased Ln-{gamma}2-chain synthesis in budding tumor cell complexes in the invasive front of various carcinomas and suggested an invasion via Ln-5. This finding was confirmed for OSCC by Kainulainen and co-workers (1997). Concerning the distribution of Ln-5 chains in OSCC, non-small-cell lung cancer, and in gastric, colon, and pancreatic adenocarcinoma, three distinct invasion-associated patterns were revealed: a retention of Ln-5-chains in the cytoplasm of invading carcinoma cell complexes; BM segments with retained Ln-5 immunostaining adjacent to segments with a complete loss of Ln-5 in the BM; and a deposition of Ln-5-chains within the stroma beneath the invading carcinoma cell complexes (Kosmehl et al. 1996 , Kosmehl et al. 1999 ; Tani et al. 1997 ; Thorup et al. 1997 ; Sordat et al. 1998 ; Maatta et al. 1999 ).

Prostate carcinoma and invasive duct or lobular carcinoma of the breast are characterized by an almost complete or total loss of Ln-5 in the BM without stromal Ln-5 deposition (Yeh et al. 1986 ; Hao et al. 1996 ; Henning et al. 1999 ). Therefore, it has recently been proposed that Ln-5 plays different roles in the invasion of different carcinomas (Henning et al. 1999 ).

Comparison of the immunolabelings of the monoclonal antibodies D4B5 (recognizing the Ln-{gamma}2-chain alone or in combination with other chains of Ln-5) and GB3 (recognizing the Ln-{gamma}2-chain exclusively in combination with other chains of Ln-5) reveals that, outside of the BM, the {gamma}2-chain is most frequently not associated with the other chains of Ln-5 in OSCC. The functional properties of complete Ln-5, single Ln-{gamma}2-chain, or Ln-5 fragments may be different. It is assumed that a complete Ln-5 is associated with keratinocyte adhesion, whereas Ln-5 fragments promote migration (Koshikawa et al. 2000 ; Sordat et al. 2000 ; Supurna and Stack 2000 ; Tsubota et al. 2000 ). Therefore, the GB3 antibody represents an ideal tool to monitor the Ln-5-mediated BM–keratinocyte adhesion in a carcinoma invasive front.

Because of the almost exclusive immunolabeling of GB3 in the BM region, the GB3 immunofluorescence signals can be considered as BM-specific. Antibodies with an immunolabeling pattern not restricted to the BM require a predefinition of the BM region for determination of measurement area.

The quantitative analysis of the Ln-5 content in the retained or re-established BM segments of an OSCC invasive front, using CLSM, reveals a clear decrease of Ln-5 in congruence to prostate and breast carcinoma. Our results reveal a reduced carcinoma cell–BM adhesion mediated by Ln-5 as a common step in the process of cancer cell invasion, obviously independent of carcinoma type. The diminution of Ln-5-mediated cell adhesion is in line with previous observations and parallels the loss of hemidesmosomal integrins. Whereas within the whole OSCC the number of integrin {alpha}6ß4-bearing carcinoma cells is increased, in the invasive front a diminution of this hemidesmosomal laminin-binding integrin is found in association with a loss of Ln immunostaining of the BM (Downer et al. 1993 ; Kosmehl et al. 1995 ). Moreover, in prostate and breast carcinoma, a loss of hemidesmosomes connecting the cell with the Ln-5-containing anchoring filaments of the BM was demonstrated (Bergstraesser et al. 1995 ; Nagle et al. 1995 ). Carcinoma invasion embraces simultaneous BM degradation as well as formation of new BM. The reduced Ln-5 content in the BM segments of invasive front can be explained by a loss of integrins essential for assembly of Ln-5 into the BM or by proteolytic activities in the context of the invasion. The ability of carcinomas to form BMs is evidenced by the occurrence of BMs in metastasis (Hida et al. 1994 ).

To our knowledge, this is the first study for the quantitative analysis of BM proteins using laser scanning microscopy. As yet there have been only a few attempts to quantify BM proteins histologically by immunogold particle counting using an electron microscope (Posthuma et al. 1986 ; Chevalier et al. 1995 ; Moriya et al. 2001 ). The quantitative evaluation of immunolabeled proteins and other fluorescent substances in situ represents an already established application of laser scanning microscopy (Brown et al. 1993 ; Huntsman et al. 1999 ; Verschure et al. 1997 ). The CLSM presents images that are almost free of out-of-focus signals and dramatically reduces interference from out-of-focus structures by allowing optical sections of a specimen with adjustment of plane of focus (Hashimoto et al. 1999 ). Nevertheless, the combination of quantitative immunofluorescence labeling and confocal microscopy needs special attention regarding methodological problems. First, there is a quantitative but not a stoichiometric relation between bound antibodies, fluorescence intensity, and absolute protein amount. Second, the measured intensity may be reduced by some excitation and emission light absorption from tissue more superficial than the plane of focus. Relative measurements between identically treated samples eliminate the use of strict quantification in the amounts of a protein and still enable one to assess whether biological conditions result in a measurable relative change in the amounts of a protein (Rastogi et al. 1997 ). This has been our rationale for reporting only relative fluorescent intensity differences among our samples.

The number of all BM defects correlates with the invasive and metastatic potential of OSCC (Harada et al. 1994 ). As recently confirmed in a tumor model, the loss of Ln-5 and hemidesmosomes correlates with invasive behavior (Tomakidi et al. 1999 ). By comparative quantitative analysis of the retained BM segments in OSCC, we have shown that a decrease of Ln-5 corresponds to an increased malignancy grade. Moreover, we have also demonstrated an intratumor gradient regarding the Ln-5 content in the BM of the tumor complexes. The lowest Ln-5 content was found in the BM of tumor complexes at the deep invasive margins of OSCC. In contrast to the periphery, in the central area of carcinoma the BM of tumor complexes showed Ln-5 immunofluorescence intensity reaching normal levels. The finding that the most reduced Ln-5-mediated cell–BM adhesion occurs in the invasive OSCC margins concurs with the suggestion that the invasive front of carcinomas represents an important area for tumor prognosis. Furthermore, our findings support the application of the histopathological malignancy grading of the invasive front for OSCC (Bryne et al. 1992 , Bryne et al. 1998 ).

Surprisingly, a significant difference was demonstrated in the Ln-5 of BM between hyperplastic lesions of oral mucosa and OSCC. In contrast to OSCC, the Ln-5 immunofluorescence in hyperplasia was increased compared to that in normal oral mucosa. Hyperplastic lesions of oral squamous epithelium represent an adaptive response to irritation. The increased Ln-5 content in hyperplasia may be considered a contribution to a higher stability of the oral mucosa by increased keratinocyte–BM adhesion. As in OSCC, the hyperplasia of oral mucosa can include an increased mitotic activity and an increase of basal-respective parabasal cells. Therefore, the decrease of Ln-5 in the retained BM segments in OSCC may represent an invasion- but not a differentiation-associated phenomenon.

In summary, the analysis of the keratinocyte–BM adhesion distinguishes benign oral squamous epithelium from invasive malignant oral squamous epithelium by the level of Ln-5 content.


  Acknowledgments

Supported by Grant ThMWK no. 973214.

We thank Dr Patricia Rousselle (Institut de Biologie et Chimie de Protéines, Université Lyon I, France) for kindly providing the monoclonal antibodies BM165 and 6F12 and for encouragement and critical advice in the ECM studies. We thank Ms Christiane Rudolph for skillful technical assistance.

Received for publication November 27, 2000; accepted April 20, 2001.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Bergstraesser LM, Srinivasan G, Jones JCR, Stahl S, Weitzman SA (1995) Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. Am J Pathol 147:1823-1839[Abstract]

Brown A, Li Y, Slaughter T, Black MM (1993) Composite microtubules of the axon: quantitative analysis of tyrosinated and acetylated tubulin along individual axonal microtubules. J Cell Sci 104:339-352[Abstract/Free Full Text]

Bryne M, Boysen M, Alfsen CG, Abeler VM, Subbo J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A (1998) The invasive front of carcinomas. Most important area for tumor prognosis? Anticancer Res 18:4757-4764[Medline]

Bryne M, Koppang HS, Lilleng R, Kjaerheim A (1992) Malignancy grading of the deep invasive margins of oral squamous cell carcinoma has high prognostic value. J Pathol 166:375-381[Medline]

Chevalier J, Masurier C, Lavaud S, Michel O, Bariety J (1995) Approach of cellular mechanisms of glomerulosclerosis in a model of accelerated aging the obese Zucker rat. CR Soc Biol 189:987-1007

Damjanov I (1990) Heterogeneity of basement membranes in normal and pathologically altered tissues. Virchows Arch 416:185-188. [A]

Downer CS, Watt FM, Speight PM (1993) Loss of {alpha}6 and ß4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol 171:183-190[Medline]

Florijn RJ, Slats J, Tanke HJ, Raap AK (1995) Analysis of antifading reagents for fluorescence microscopy. Cytometry 19:177-182[Medline]

Ghadially FN (1997) Ultrastructural Pathology of the Cell and Matrix. Boston, Butterworth–Heinemann

Hao J, Yang Y, McDaniel K, Dalkin BL, Cress AE, Nagle RB (1996) Differential expression of laminin-5 ({alpha}3ß3{gamma}2) by human malignant and normal prostate. Am J Pathol 149:1341-1349[Abstract]

Harada T, Shinohara M, Nakamura S, Oka M (1994) An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 424:257-266[Medline]

Hashimoto H, Ishikawa H, Kusakabe M (1999) Preparation of whole mounts and thick sections for conical microscopy. Methods Enzymol 307:84-107[Medline]

Henning K, Berndt A, Katenkamp D, Kosmehl H (1999) Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast. Histopathology 34:305-309[Medline]

Hida JI, Matsuda T, Kitaoka M, Machidera N, Kubo R, Ysutomi M (1994) The role of basement membrane in colorectal cancer invasion and liver metastasis. Cancer 74:592-598[Medline]

Hsi BL, Yeh CJG (1986) Monoclonal antibodies to human amnion. J Reprod Immunol 9:11-21[Medline]

Huntsman D, Resau JH, Klineberg E, Auersperg N (1999) Comparision of c-met expression in ovarian epithelial tumors and normal epithelium of the female reproductive tract by quantitative laser scan microscopy. Am J Pathol 155:343-348[Abstract/Free Full Text]

Kainulainen T, Autio–Harmainen H, Oikarinen A, Salo S, Tryggvason K, Salo T (1997) Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 136:331-336[Medline]

Koshikawa N, Gianelli G, Cirulli V, Miyazaki K, Quaranta V (2000) Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 143:615-624

Kosmehl H, Berndt A, Katenkamp D (1996) Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch 429:311-322[Medline]

Kosmehl H, Berndt A, Katenkamp D, Hyckel P, Stiller KJ, Gabler U, Langbein L, Reh T (1995) Integrin receptors and their relationship to cellular proliferation and differentiation of oral squamous cell carcinoma. A quantitative immunohistochemical study. J Oral Pathol Med 24:343-348[Medline]

Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, Hyckel P, Zardi L, Katenkamp D (1999) Distribution of Laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 81:1071-1079[Medline]

Maatta M, Soini Y, Paako P, Salo S, Tryggvason K, Autio–Harmainen H (1999) Expression of the laminin {gamma}2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. J Pathol 188:361-368[Medline]

Marinkovich PM, Lunstrum GP, Keene DR, Burgeson RE (1992) The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119:695-703[Abstract]

Matsui C, Nelson CF, Hernandez GT, Herron GS, Bauer EA, Hoeffler WK (1995) {gamma}2 chain of laminin-5 is recognized by monoclonal antibody GB3. J Invest Dermatol 105:648-652[Abstract]

Matsui C, Pereira P, Wang CK, Nelson CF, Kutzkey T, Lanigan C, Woodley D, Morohashi M, Welsh EA, Hoeffler WK (1998) Extent of laminin-5 assembly and secretion effect junctional epidermolysis bullosa phenotype. J Exp Med 187:1273-1283[Abstract/Free Full Text]

Miner JH, Sanes JR (1994) Collagen IV {alpha}3,{alpha}4 and {alpha}5 chains in rodent basal laminae: sequence, distribution, associations with laminins, and developmental switches. J Cell Biol 127:879-887[Abstract]

Mizushima H, Koshikawa N, Moriyama K, Takamura H, Nagashima Y, Hirahara F, Miyazaki K (1998) Wide distribution of laminin-5 gamma 2 chain in basement membranes of various human tissues. Horm Res 50(suppl 2):7-14[Medline]

Moriya T, Groppoli TJ, Kim Y, Mauer M (2001) Quantitative immunoelectron microscopy of type VI collagen in glomeruli in type I diabetic patients. Kidney Int 59:317-323[Medline]

Nagle RB, Hao J, Knox JD, Dalkin BL, Clark V, Cress AE (1995) Expression of hemidesmosomal and extracellular matrix protein by normal and malignant human prostate tissue. Am J Pathol 146:1498-1507[Abstract]

Odermatt BF, Lang AB, Rüttner JR, Winterhalter KH, Trüeb B (1984) Monoclonal antibodies to human type IV collagen: useful reagents to demonstrate the heterotrimeric nature of the molecule. Proc Natl Acad Sci USA 81:7343-7347[Abstract]

Pindborg JJ, Reichart PA, Smith CJ, van der Wal I (1997) Histological Typing of Cancer and Precancer of the Oral Mucosa/World Health Organization. Berlin, Springer-Verlag

Posthuma G, Slot JW, Geuze HJ (1986) A quantitative immunoelectronmicroscopic study of amylase and chymotrypsinogen in peri- and tele-insular cells of the rat exocrine pancreas. J Histochem Cytochem 34:203-207[Abstract]

Pyke C, Roemer J, Kallunki P, Lund LR, Ralfkiaer E, Danoe K, Tryggvason K (1994) The {gamma}2 chain of kalinin/laminin-5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 145:782-791[Abstract]

Rastogi KS, Cooper RL, Shi ZQ, Vranic M (1997) Quantitative measurement of islet glucagon response to hypoclycemia by conical fluorescence imaging in diabetic rats. Endocrine Rev 7:367-375

Rousselle P, Lunstrum GP, Keene DR, Burgeson RE (1991) Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 114:567-576[Abstract]

Sordat I, Bosman FT, Dorta G, Rouselle P, Aberdam D, Blum AL, Sordat B (1998) Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 185:44-52[Medline]

Sordat I, Rousselle P, Chaubert P, Petermann O, Aberdam D, Bosman FT, Sordat B (2000) Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue microenvironment. Int J Cancer 88:708-717[Medline]

Strassburger S, Berndt A, Hyckel P, Katenkamp D, Kosmehl H (1998) Differential expression of laminin chains in the human major salivary gland. Histochem J 30:81-88[Medline]

Supurna G, Stack MS (2000) Proteolytic modifications of laminins: functional consequences. Microsc Res Tech 51:238-246[Medline]

Tani T, Lumme A, Linnala A, Kivilaakso E, Kiviluoto T, Burgeson RE, Kangas L, Leivo I, Virtanen I (1997) Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol 151:1289-1302[Abstract]

Thorup AK, Dabelsteen E, Schou S, Gil SG, Carter WG, Reibel J (1997) Differential expression of integrins and laminin-5 in normal oral epithelia. APMIS 105:519-530[Medline]

Tomakidi P, Mirancea N, Fusenig NE, Herold–Mende C, Bosch FX, Breitkreuz D (1999) Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts. Differentiation 64:263-275[Medline]

Tsubota Y, Mizushima H, Hirosaki T, Higashi S, Yasumitsu H, Miyazaki K (2000) Isolation and activity of proteolytic fragment of laminin-5 {alpha}3 chain. Biochem Biophys Res Commun 278:614-620[Medline]

Verschure PJ, Van Marle J, Van Noorden CJF, Van den Berg WB (1997) The contribution of quantitative conical laser scanning microscopy in cartilage research: chondrocyte insulin-like growth factor-1 receptor in health and pathology. Microsc Res Tech 37:285-298[Medline]

Yeh CJG, Hsi BL, Ettore F (1986) Normal epithelial antigens recognised by GB3 and GB5 are diminished and lost in infiltrating human breast carcinomas. Breast Cancer Res Treat 8:117-123[Medline]